The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2020 | Updates from the German CLL Study Group
Michael Hallek, MD, University Hospital of Cologne, Cologne, Germany, updates us on the latest news from the German CLL Study Group including updates from CLL14 (NCT02242942) to be presented at ASH, as well as ongoing trials such as CLL17 (NCT03701282), investigating ibrutinib and obinutuzumab with or without venetoclax. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
